Quick Answer
Roivant Sciences Ltd. reported Stockholders Equity of $4.69 billion for fiscal year 2025.
Roivant Sciences Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.69B | -21.5% |
| 2024 | $5.97B | +415.5% |
| 2023 | $1.16B | -30.1% |
| 2022 | $1.66B | -7.8% |
| 2021 | $1.80B | -13.8% |
| 2020 | $2.09B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.27B | -17.7% | -2.1% |
| September 30, 2025 | $4.36B | -15.3% | +0.4% |
| June 30, 2025 | $4.35B | -20.0% | -7.3% |
| March 31, 2025 | $4.69B | -21.5% | -9.7% |
| December 31, 2024 | $5.19B | -14.8% | +0.7% |
| September 30, 2024 | $5.15B | +443.3% | -5.2% |
| June 30, 2024 | $5.44B | +496.8% | -8.9% |
| March 31, 2024 | $5.97B | +415.5% | -2.0% |
- Roivant Sciences Ltd. showed a decrease of -21.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Roivant Sciences Ltd.’s stockholders equity has grown by 124.7% (from $2.09 billion to $4.69 billion).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: